You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 31, 2025

Bulk Pharmaceutical API Sources for RECTIV


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for RECTIV

Vendor Vendor Homepage Vendor Sku API Url
Clearsynth ⤷  Get Started Free CS-O-01966 ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free T-002_CERILLIAN ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free T-021_CERILLIAN ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for RECTIV (Nitroglycerin)

Last updated: August 2, 2025

Introduction

Rectiv, a topical formulation of nitroglycerin, is prescribed predominantly for managing anal fissures by promoting blood flow and facilitating healing. As a pharmaceutical product requiring stringent safety and quality standards, the procurement of high-quality active pharmaceutical ingredients (APIs) such as nitroglycerin is critical for manufacturers. This article examines the global landscape of bulk API sources for rectiv, emphasizing quality, regulatory compliance, and supply chain considerations.

Overview of Nitroglycerin as an API

Nitroglycerin (glyceryl trinitrate) is an organic nitrate used in both cardiovascular therapy and topical formulations. Its widespread industrial manufacture and established synthesis routes have fostered a global supply chain comprising reputed chemical and pharmaceutical API manufacturers. Given its classification as a potent vasodilator, sourcing high-purity nitroglycerin necessitates adherence to rigorous pharmacopeial standards, including USP, EP, and JP specifications.

Global API Manufacturing Hubs

1. India

India emerges as a significant producer of nitroglycerin API, buoyed by its robust pharmaceutical sector. Key manufacturers include:

  • Glycinex Pharma: Specializes in manufacturing organic nitrates, including nitroglycerin, adhering to international standards.
  • Mundipharma India: Offers pharmaceutical-grade APIs meeting cGMP requirements, with supply chains serving both local and international markets.

Advantages: Cost-effective production with a well-established regulatory framework for APIs; capacity for large-scale synthesis.

Challenges: Ensuring rigorous quality assurance measures to meet global standards, especially for topical APIs requiring high purity.

2. China

China's API industry has expanded significantly, with numerous suppliers of nitroglycerin:

  • North China Pharmaceutical Group (NCPC): Provides high-purity nitroglycerin API, compliant with international pharmacopeial monographs.
  • Shandong Xinhua Pharmaceutical: Offers competitive pricing and reliable supply chains.

Advantages: Competitive pricing and high production capacity.

Challenges: Variability in quality control standards; procurement requires comprehensive validation and audits.

3. Europe

European manufacturers prioritize quality, regulatory compliance, and consistency:

  • BASF (Germany): Supplies pharmaceutical-grade nitroglycerin APIs, adhering to strict quality standards and regulatory compliance, including FDA and EMA standards.
  • Bolder BioPATH (Belgium): Offers custom synthesis of nitroglycerin with a focus on stability and purity.

Advantages: High-quality APIs compliant with strict European pharmacopeias; reliable regulatory support.

Challenges: Higher costs relative to Asian suppliers; limited capacity for bulk procurement compared to Asian manufacturers.

4. United States

The US hosts specialized chemical suppliers with advanced manufacturing standards:

  • Pfizer (formerly): Historically produced nitroglycerin for pharmaceutical use, though production has transitioned to other suppliers or specialized contract manufacturers.
  • Contract API manufacturers: A network of US-based contract manufacturing organizations (CMOs) provides high-quality nitroglycerin APIs, often with comprehensive regulatory documentation.

Advantages: Stringent quality controls; established GMP compliance.

Challenges: Premium pricing and regulatory hurdles may limit procurement scalability for certain formulations.

Key Considerations in API Sourcing

Quality and Compliance

APIs destined for rectiv must meet high purity standards, free from residual solvents, heavy metals, or other contaminants. Suppliers should provide comprehensive Certificates of Analysis (CoAs) and comply with pharmacopeial monographs (USP <821> Nitroglycerin).

Regulatory Status

Manufacturers must verify supplier compliance with cGMP standards, and APIs should possess appropriate regulatory validations, especially for products marketed internationally.

Supply Chain Reliability

Long-term supply stability is crucial to prevent manufacturing disruptions. Diversification of suppliers, inventory buffers, and supplier qualification audits are essential strategies.

Price and Lead Times

Balancing cost with quality and regulatory compliance influences procurement decisions. Efficient logistics and inventory management optimize lead times.

Emerging Trends in API Sourcing

  • Synthetic innovation: New synthetic routes improve yields and reduce impurities.
  • Local manufacturing: Countries emphasizing API self-sufficiency reduce dependency on imports.
  • API characterization: Enhanced analytical techniques ensure batch-to-batch consistency.

Conclusion

Sourcing bulk nitroglycerin API for rectiv demands a comprehensive evaluation of geographic location, quality standards, regulatory compliance, and supply chain robustness. Known global suppliers from India, China, Europe, and the US dominate the market, each offering distinct advantages and potential challenges. The ultimate procurement decision hinges on balancing quality, cost, compliance, and supply continuity, ensuring the final product's safety and efficacy.


Key Takeaways

  • Quality Assurance: Prioritize suppliers that comply with pharmacopeial standards and possess detailed documentation, including COAs and stability data.
  • Geographical Diversification: Engage multiple suppliers across regions to mitigate geopolitical or supply chain disruptions.
  • Regulatory Alignment: Confirm suppliers' adherence to cGMP standards and past audits, especially when exporting to regulated markets.
  • Cost vs. Compliance: Weigh the lower costs of Asian suppliers against the higher regulatory and quality assurance standards of European and US manufacturers.
  • Continuous Monitoring: Keep abreast of technological advances and geopolitical shifts affecting API production and supply chains.

FAQs

1. What are the primary challenges in sourcing nitroglycerin APIs for rectiv?
Ensuring high purity, regulatory compliance, and supply chain stability, particularly given nitroglycerin’s sensitive nature and potential regulatory restrictions.

2. Which regions provide the most reliable nitroglycerin API sources?
Europe and the US offer the highest compliance standards, while India and China provide cost-effective alternatives with growing quality assurance capacities.

3. How can manufacturers verify the quality of a nitroglycerin API supplier?
Through auditing GMP compliance, reviewing Certificates of Analysis, evaluating past regulatory inspections, and performing internal quality testing.

4. Are there alternatives to traditional suppliers for sourcing nitroglycerin?
Emerging local manufacturing and synthetic innovations may reduce dependency on traditional supply chains, subject to regulatory approval.

5. How does API sourcing impact regulatory approval for rectiv?
Consistent sourcing from approved suppliers aligned with regulatory standards is critical to maintain approvals and ensure product safety and efficacy.


Sources

[1] United States Pharmacopeia (USP). "Nitroglycerin monograph," USP-NF, 2023.
[2] European Pharmacopoeia. "Nitroglycerin," EP, 2023.
[3] "Global API Market," Industry Reports, 2022.
[4] G. Kumar, "The API Supply Chain: Challenges and Strategies," Pharmaceutical Technology, 2021.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.